Immunovant: CEO Eric Venker disposes of common shares worth $2.93 million

Immunovant CEO and director Eric Venker disposed of 85,886 shares on Oct. 1, 2026, at $33.65 per share, and 3,506 shares on Oct. 2, 2026, at $34.11 per share to cover tax withholding. He also acquired 92,187 shares on Oct. 1, 2026, at $14.46 per share via an exercise transaction. His direct stake is now 257,075 shares.